Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil–lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma
Open Access
- 1 December 2016
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 116 (1), 85-90
- https://doi.org/10.1038/bjc.2016.393
Abstract
In the cohort studied, an elevated (⩾10.0) pretreatment CRP level and elevated dNLR (>2) were robust independent predictors of CSS and MFS. Our data suggest that CRP might be superior to both NLR and dNLR.Keywords
This publication has 29 references indexed in Scilit:
- C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewPLOS ONE, 2015
- EAU Guidelines on Renal Cell Carcinoma: 2014 UpdateEuropean Urology, 2015
- Increased preoperative levels of plasma fibrinogen and d dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristicsUrologic Oncology, 2014
- The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal NeoplasiaThe American Journal of Surgical Pathology, 2013
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012European Journal of Cancer, 2013
- Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance statusInternational Journal of Clinical Oncology, 2013
- Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patientsBMC Cancer, 2012
- A derived neutrophil to lymphocyte ratio predicts survival in patients with cancerBritish Journal of Cancer, 2012
- Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survivalInternational Urology and Nephrology, 2012
- C‐reactive protein is an informative predictor of renal cell carcinoma‐specific mortalityCancer, 2007